Breaking News

Thibault Jonckheere Named CEO of Exothera

The viral vector CDMO spinoff of Univercells is making an intranasal vaccine candidate for Covid-19 treatment.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Exothera, a Univercells company and viral vector contract development and manufacturing organization, named Thibault Jonckheere as CEO.   Thibault joined Exothera as deputy CEO following last year’s carve-out of the company from Univercells. The company has since experienced rapid growth, more than tripling its number of collaborators to over one hundred. The beginning of this year also marked the signing of Exothera’s first contracts, including a development agreement with CyanVac for its Covid...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters